Health
India’s drug controller approves phase 2, 3 human trials of COVID-19 vaccine – China.org.cn
NEW DELHI, Aug. 3 (Xinhua) — Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) to conduct phase 2 and 3 human clinical trials of COVID-19 vaccine developed by Oxford University, officials said Monday.
“The DCGI has given approval to SII, Pune to conduct Phase II and III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India. This will hasten the development of the COVID-19 vaccine,” a statement issued by country’s fed…
-
Business23 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News19 hours agoWilliam Robinson dies aged 89
-
Business23 hours agoWhat to do with these 3 ASX 200 retail shares after strong price runs: experts
-
General19 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase